Euthyroid Graves orbitopathy

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:466682H05.2
Who is this for?
Show terms as
1Active trials1Specialists8Treatment centers

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Euthyroid Graves orbitopathy (also called euthyroid Graves ophthalmopathy or euthyroid thyroid eye disease) is a rare condition where the eyes develop the same swelling and inflammation seen in Graves' disease, but without the thyroid gland being overactive. In typical Graves' disease, the immune system attacks the thyroid gland, causing it to produce too much thyroid hormone, and often also attacks the tissues around the eyes. In euthyroid Graves orbitopathy, the thyroid hormone levels remain normal (euthyroid means normal thyroid function), yet the immune system still targets the muscles and fatty tissue behind the eyes. This leads to eye bulging (proptosis), swelling of the eyelids, double vision, eye pain, redness, and in severe cases, pressure on the optic nerve that can threaten vision. The condition can affect one or both eyes and tends to occur in adults. Because thyroid blood tests come back normal, diagnosis can be delayed or initially missed. Doctors rely on clinical examination, imaging of the eye sockets (usually CT or MRI scans), and blood tests for thyroid antibodies — particularly thyroid-stimulating immunoglobulins (TSI) or TSH receptor antibodies (TRAb) — which may be positive even when thyroid function is normal. Treatment is similar to that used for Graves orbitopathy with thyroid dysfunction and may include lubricating eye drops, corticosteroids to reduce inflammation, orbital radiation therapy, and in some cases surgery to decompress the eye socket. The FDA-approved biologic teprotumumab (Tepezza), which targets the insulin-like growth factor 1 receptor, has been approved for thyroid eye disease and may also be considered. Monitoring by an experienced ophthalmologist is essential to prevent vision loss.

Also known as:

Key symptoms:

Bulging of one or both eyes (proptosis)Swollen or puffy eyelidsRedness and irritation of the eyesDouble visionEye pain or discomfort, especially with eye movementFeeling of pressure behind the eyesDry or gritty eyesExcessive tearingDifficulty closing the eyelids completelySensitivity to lightBlurred visionRestricted eye movementChanges in appearance of the eyesIn severe cases, loss of vision from optic nerve compression

Inheritance

Multifactorial

Caused by a mix of several genes and environmental factors

Age of Onset

Adult

Begins in adulthood (age 18 or older)

Orphanet ↗NORD ↗

FDA & Trial Timeline

1 event
Jul 2025Thyroidectomy for Graves' Disease or Amiodarone-induced Thyrotoxicosis

Andrea Goldmann

TrialRECRUITING

Data sourced from FDA regulatory filings and ClinicalTrials.gov. Updated periodically.

Treatments

No FDA-approved treatments are currently listed for Euthyroid Graves orbitopathy.

1 clinical trialare actively recruiting — trials can provide access to cutting-edge therapies.

View clinical trials →

Clinical Trials

1 recruitingView all trials with filters →
Other1 trial
Thyroidectomy for Graves' Disease or Amiodarone-induced Thyrotoxicosis
Actively Recruiting
PI: Andrea Goldmann, MD (Kantonsspital Winterthur KSW) · Sites: Aalst; Nancy +13 more · Age: 1899 yrs

Specialists

1 foundView all specialists →
AG
Andrea Goldmann
PHOENIX, AZ
Specialist
PI on 1 active trial

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Travel Grants

No travel grants are currently matched to Euthyroid Graves orbitopathy.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Euthyroid Graves orbitopathyForum →

No community posts yet. Be the first to share your experience with Euthyroid Graves orbitopathy.

Start the conversation →

Latest news about Euthyroid Graves orbitopathy

Disease timeline:

New recruiting trial: Thyroidectomy for Graves' Disease or Amiodarone-induced Thyrotoxicosis

A new clinical trial is recruiting patients for Euthyroid Graves orbitopathy

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.Is my disease in the active inflammatory phase or has it stabilized?,Should I be tested for thyroid antibodies even though my thyroid levels are normal?,Am I at risk of developing thyroid problems in the future, and how often should my thyroid be checked?,Is teprotumumab (Tepezza) an appropriate treatment option for me?,What signs should I watch for that would indicate my vision is at risk?,Will I need surgery, and if so, what type and when?,Are there lifestyle changes I can make to help manage or slow the disease?

Common questions about Euthyroid Graves orbitopathy

What is Euthyroid Graves orbitopathy?

Euthyroid Graves orbitopathy (also called euthyroid Graves ophthalmopathy or euthyroid thyroid eye disease) is a rare condition where the eyes develop the same swelling and inflammation seen in Graves' disease, but without the thyroid gland being overactive. In typical Graves' disease, the immune system attacks the thyroid gland, causing it to produce too much thyroid hormone, and often also attacks the tissues around the eyes. In euthyroid Graves orbitopathy, the thyroid hormone levels remain normal (euthyroid means normal thyroid function), yet the immune system still targets the muscles and

How is Euthyroid Graves orbitopathy inherited?

Euthyroid Graves orbitopathy follows a multifactorial inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Euthyroid Graves orbitopathy typically begin?

Typical onset of Euthyroid Graves orbitopathy is adult. Age of onset can vary across affected individuals.

Are there clinical trials for Euthyroid Graves orbitopathy?

Yes — 1 recruiting clinical trial is currently listed for Euthyroid Graves orbitopathy on UniteRare. See the clinical trials section on this page for phase, sponsor, and site details sourced from ClinicalTrials.gov.

Which specialists treat Euthyroid Graves orbitopathy?

1 specialists and care centers treating Euthyroid Graves orbitopathy are listed on UniteRare, sourced from ClinicalTrials.gov principal investigators, published research, and the NPPES NPI registry.